Background -Aneuploidy appears to be a highly specific marker for cancer, and measurement of cellular DNA content by flow cytometry is rapid and reliable. This study was undertaken to determine if the addition of DNA analysis improved the sensitivity of cytological diagnosis of malignancy in pleural fluid. Malignant tumours generally exhibit abnormal amounts of DNA, and measurement of DNA content by flow cytometry has been used to complement cytological or histological diagnosis.5 However, details of the accuracy of flow cytometry for differentiating between benign and malignant pleural effusions remain scanty.67 We have prospectively studied pleural effusions using both conventional cytopathology and flow cytometry to determine if the addition of DNA analysis improves the sensitivity of cytological diagnosis.
Abstract
Background -Aneuploidy appears to be a highly specific marker for cancer, and measurement of cellular DNA content by flow cytometry is rapid and reliable. This study was undertaken to determine if the addition of DNA analysis improved the sensitivity of cytological diagnosis of malignancy in pleural fluid. Methods -Pleural effusions from 92 patients were studied by cytological examination and flow cytometry. Results -In 41 patients the final diagnosis was malignancy, there were 40 cases of benign effusions including 22 with pleural tuberculosis, and in the remaining 11 patients with biopsy proven cancer the presence of malignant cells was not found by cytological and histological means in the pleural fluid. Aneuploidy and cytological malignancy were found in 14 samples. There Malignant tumours generally exhibit abnormal amounts of DNA, and measurement of DNA content by flow cytometry has been used to complement cytological or histological diagnosis. 5 However, details of the accuracy of flow cytometry for differentiating between benign and malignant pleural effusions remain scanty.67 We have prospectively studied pleural effusions using both conventional cytopathology and flow cytometry to determine if the addition of DNA analysis improves the sensitivity of cytological diagnosis.
Methods

PATIENTS AND SAMPLES
Between December 1991 and April 1993 92 samples of pleural fluid obtained from consecutive unselected patients undergoing a therapeutic or diagnostic thoracocentesis were examined. According to the final diagnosis achieved the effusions were divided into three groups: group I -malignant effusions where a diagnosis of malignancy was made by cytological examination of pleural fluid, or by histological examination of parietal pleural biopsy samples obtained from a blind biopsy or thoracoscopy, or both; group II -benign effusions that included 22 with tuberculosis, four parapneumonic effusions, three cases of congestive heart failure, two cases of collagen disease, one nephrotic syndrome, one cirrhosis, and seven with unidentified causes; group III -effusions associated with known malignancy where cytological examination of the pleural fluid and histological testing of biopsy samples obtained by both pleural biopsy and thoracoscopy could not demonstrate metastases.
CYTOLOGICAL TESTING AND FLOW CYTOMETRY
The samples were obtained from fresh pleural fluid and sent for conventional diagnostic cytological testing which was performed on cells stained with a Papanicolau stain and interpreted by a cytopathologist. An aliquot of 20-50 ml of pleural fluid was also sent for flow cytometric analysis and processed within four hours. The samples were centrifuged at 350g for five minutes, the supernatant was discarded, and the cell pellet was resuspended with phosphate buffered saline (PBS). The suspension was filtered through a 50 gm pore size nylon mesh (Pall Utipor SQ 40S Pall, Spain) to remove large clumps, and was then washed in PBS and the concentration adjusted to 1 x 108 nuclei per sample. Samples containing red blood cells were lysed before being processed.
Cell suspensions were frozen by adding 1-5 ml citrate buffer solution containing sucrose and dimethyl sulphoxide, stored at -80'C, and melted in a water bath at 37'C. At the same time peripheral blood from healthy volunteers was processed and added for analysis as an external control to provide a reference point for determining the DNA index within a given sample. Once melted, the samples were centrifuged for five minutes at 350g at room temperature and the supernatant was aspirated. The samples were stained as described elsewhere. 8 Samples were run in the flow cytometer for between 15 minutes and three hours after the addition of propidium iodide solution using a Facscan Analyzer flow cytometer (Becton Dickinson, Mountain View, California, USA). A minimum of 10 000 nuclei were collected in each DNA histogram.
The coefficient of variation (CV) of the diploid peaks was always below 5%, otherwise samples were excluded from the series. The percentage of the S phase fraction was calculated using the "broadened rectangle" mathematical model (Hewlett-Packard software). As malignant effusions may be characterised by abnormal proliferative activity we calculated the percentage of cells in the S phase and found a significantly higher S phase fraction in malignant pleural effusions than in benign ones (7-5 (1-45) v 1-99 (0 24); p<0 01). Similarly, a correlation was seen between the S phase fraction and DNA index (r = 0 57; p <0.05).
The sensitivity of DNA analysis was 51*2%, a lower figure than that obtained from cytological analysis (63-4%). Considering both methods together, the sensitivity was 80-4%. In contrast, the specificity of DNA analysis was only 74-5% compared with 100% for conventional cytological examination. This low specificity was due mainly to the large number of cases with pleural tuberculosis and aneuploid cells (seven of 22).
Discussion
Neoplastic lesions often undergo chromosomal aberrations resulting in the appearance of non-de Castro, Molero, Acosta, 'ulia-Serdai, Caminero, Cabrera, Carrillo diploid clones within the tumour cell population. The finding of aneuploidy is therefore highly suggestive of malignancy with pronounced karyotype abnormalities. Flow cytometry allows rapid quantitative measurement of nuclear DNA and could therefore be used as a tool for differentiating between benign and malignant cells.
In our series DNA analysis was falsely negative in 20 cases, a sensitivity of 51 2%. Conventional cytological examination had a sensitivity of 63-4%. When both techniques were combined the sensitivity achieved 80-4%. There is only one study that reports aneuploid DNA patterns in all malignant effusions studied, although some of them showed minimal deviation of DNA diploid standard.7 All other communications, dealing with different body fluids, have shown sensitivities between 30% and 88%.6I'll These results may be due to: (1) a lack of sensitivity of flow cytometric analysis which cannot detect karyotype abnormalities belonging to one or two chromosomes; (2) some cancer cells being diploid as occurs in approximately 20% of all solid tumours; and (3) pleural effusions, which contain a small number of malignant cells, may require a larger sample than the one studied to assess aneuploidy.
With the exception of Hedley et al'0 and Schneller et al"3 all other authors have found some false positive results with a specificity ranging from 86% to 96%.67111215 However, the definition of aneuploidy has not always been uniform. In our study 10 samples were considered false positive because of abnormal DNA content with no evidence of malignancy. It is noteworthy that almost one third of the tuberculous effusions showed DNA aneuploidy, although five out of seven had a pseudodiploid pattern which is an unreliable marker of malignancy. The mechanisms by which Mycobacterium tuberculosis produces DNA aneuploidy are not clear. T lymphocytes specifically sensitised to tuberculous protein might be responsible for the discrete changes in DNA ploidy patterns. The kinetics of PPD reactive T lymphocytes in the pleural space may influence the finding of aneuploidy in only some patients. The large number of cases of tuberculosis in our series may explain the low specificity observed.
In conclusion, since DNA analysis of cells in malignant pleural effusions was both less sensitive and specific than cytological diagnosis, flow cytometric analysis is not recommended for routine use. 
